Pharmagreen Biotech
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$568,775 and profit margin reached -18972%. Total operating expenses were $467,563.

Profit Margin

Pharmagreen Biotech Inc. (OTC:PHBI): Profit margin
2017 0 -18.98K
2018 0 -1.07M
2019 0 -890.38K
2020 0 -3.32M
2021 0 -5.53M
2022 0 -633.99K
2023 2.99K -568.77K -18971.81%

PHBI Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
2.99K000000
Cost of revenue
2.06K0434.60K434.60K000
Gross profit
9300-434.60K-434.60K000
Operating exp.
Research and development
00003.95K7.61K0
Selling and marketing
43.89K00003.66K-387.66K
Total operating expenses
467.56K1.06M752.72K485.74K652.10K669.79K18.98K
Operating income
-474.00K-1.06M-514.78K-271.27K-652.10K-1.06M-18.99K
Other income (expenses), net
-94.79K194.24K-4.01M-1.80M-116.70K-399.91K4
Income before tax
-568.79K-875.50K-4.53M-2.48M-768.81K-1.07M-18.98K
Income tax expense
0-241.51K1.00M842.00K121.57K399.91K253.97K
Net income
-568.77K-633.99K-5.53M-3.32M-890.38K-1.07M-18.98K
Earnings per share
Basic EPS
-0.00-0.00-0.01-0.04-0.01-0.04-0.06
Diluted EPS
-0.00-0.00-0.01-0.04-0.01-0.04-0.06
Data sourceData sourceData sourceData source